JBT Marel’s second quarter saw solid revenue growth driven by resilient demand in both the Protein Solutions and Prepared Food and Beverage segments. However, the market reacted negatively as the company’s adjusted profit fell short of Wall Street’s expectations, reflecting operational challenges. Management attributed the underperformance in Prepared Food and Beverage to logistics constraints and disruptions from ongoing manufacturing footprint optimization. CEO Brian Deck noted, “We were short about $20 million in revenue in the quarter, all of which being in the Prepared Food and Beverage segment,” highlighting the impact of these execution issues on both revenue and margins.
Is now the time to buy JBTM? Find out in our full research report (it’s free for active Edge members).
JBT Marel (JBTM) Q2 CY2026 Highlights:
- Revenue: $981 million vs analyst estimates of $982.2 million (4.9% year-on-year growth, in line)
- Adjusted EPS: $1.95 vs analyst expectations of $2.02 (3.4% miss)
- Adjusted EBITDA: $168 million vs analyst estimates of $167.7 million (17.1% margin, in line)
- The company reconfirmed its revenue guidance for the full year of $4.03 billion at the midpoint
- Management lowered its full-year Adjusted EPS guidance to $8.10 at the midpoint, a 1.8% decrease
- Operating Margin: 4.7%, in line with the same quarter last year
- Backlog: $1.54 billion at quarter end, up 10% year on year
- Market Capitalization: $6.36 billion
While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From JBT Marel’s Q2 Earnings Call
- Mircea Dobre (Baird) asked about the revenue and margin cadence for the Prepared Food and Beverage segment, with CEO Brian Deck clarifying that delayed Q2 revenue would be spread over the second half of the year and margins should improve as disruptions abate.
- Justin Ages (CJS Securities) inquired about strength in Protein Solutions outside poultry, and Deck explained that while poultry remains the growth driver, pork and fish are showing modest gains with beef remaining weak due to low cattle inventory.
- Ross Sparenblek (William Blair) raised questions about pricing actions and the impact of logistics inflation, with Deck noting that price increases are embedded in backlog but acknowledged a lag in cost recovery for inbound logistics.
- Walter Liptak (Seaport Research) asked about the timeline and challenges of facility consolidations, and Deck responded that consolidations will phase through 2027, with later moves expected to be smoother as receiving plants are already familiar with the products.
- Ian Zaffino (Oppenheimer) questioned end-customer demand trends, and management described mixed consumer behavior, with protein demand stable but some trade-down to value products in other food categories.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will be watching (1) the pace and impact of manufacturing footprint consolidations on margin recovery, (2) order flow and backlog conversion in both Protein Solutions and Prepared Food and Beverage, and (3) the company’s ability to manage cost inflation and logistics pressures. Progress in warehouse automation restructuring and efficiency gains will also be critical signposts.
JBT Marel currently trades at $123.04, down from $142.25 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).
Our Favorite Stocks Right Now
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
